{"id":741396,"date":"2020-07-02T02:00:00","date_gmt":"2020-07-02T02:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/"},"modified":"2025-03-07T23:37:09","modified_gmt":"2025-03-08T04:37:09","slug":"merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/","title":{"rendered":"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals"},"content":{"rendered":"<div class=\"q4default\">\n<p class=\"bwalignc\">\n  <b>Further Solidifies Merck Animal Health\u2019s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection<\/b>\n<\/p>\n<p class=\"bwalignc\">\n  <b>Complements Merck Animal Health\u2019s Broad Portfolio of Vaccines and Pharmaceuticals<\/b>\n<\/p>\n<p>    MADISON, N.J.&#8211;(BUSINESS WIRE)&#8211;<br \/>\nMerck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck &amp; Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its previously announced acquisition of the U.S. rights to SENTINEL\u00ae FLAVOR TABS\u00ae and SENTINEL\u00ae SPECTRUM\u00ae Chews in the Companion Animal category from Virbac (NYSE Euronext:VIRP).\n<\/p>\n<p>\nComprehensive parasite protection is an essential part of canine overall health and well-being. \u201cOur veterinary medicines, including parasiticides, and vaccines continue to transform the animal health industry and further solidify our position in the U.S. Companion Animal category,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cThe extensive breadth and depth of our product portfolio enhances our offerings of comprehensive pet care solutions, which provide a full range of complementary solutions for our customers to improve the health and well-being of animals and the people who care for them.\u201d\n<\/p>\n<p>\n  <strong>About Merck Animal Health<\/strong>\n<\/p>\n<p>\nFor more than a century, Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world\u2019s most challenging diseases. Merck Animal Health, a division of Merck &amp; Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck. Through its commitment to <i>The<\/i><i>Science of Healthier Animals\u00ae<\/i>, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&amp;D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck-animal-health.com%2F&amp;esheet=52244266&amp;newsitemid=20200701005757&amp;lan=en-US&amp;anchor=www.merck-animal-health.com&amp;index=1&amp;md5=81538d4f38513c31249c80f8f541c067\">www.merck-animal-health.com<\/a> or connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fshowcase%2Fmerck-animal-health%2F&amp;esheet=52244266&amp;newsitemid=20200701005757&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=da61c0509919102d35c251c2f70060cd\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fmerckanimalhealth&amp;esheet=52244266&amp;newsitemid=20200701005757&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=0547f1382b11002c0756aaa37d735e50\">Facebook<\/a>, and Twitter at @MerckAH.\n<\/p>\n<p>\n  <b>About Virbac <\/b>\n<\/p>\n<p>\nVirbac offers veterinarians, farmers and pet owners in more than 100 countries a practical range of products and services for diagnosing, preventing and treating the majority of diseases while improving quality of life for animals. With these innovative solutions covering more than 50 species, Virbac contributes day after day to shaping the future of animal health.\n<\/p>\n<p>\n  <b>Forward-Looking Statement of Merck &amp; Co., Inc., Kenilworth, N.J., USA<\/b>\n<\/p>\n<p>\nThis news release of Merck &amp; Co., Inc., Kenilworth, N.J., USA (the \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company\u2019s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.\n<\/p>\n<p>\nRisks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company\u2019s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company\u2019s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and\/or regulatory actions.\n<\/p>\n<p>\nThe company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company\u2019s 2019 Annual Report on Form 10-K and the company\u2019s other filings with the Securities and Exchange Commission (SEC) available at the SEC\u2019s Internet site (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52244266&amp;newsitemid=20200701005757&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=2619435a02eb83713cf9fc2195ca0ce0\">www.sec.gov<\/a>).\n<\/p>\n<p>\n  <img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"><br \/>\n  <span class=\"bwct31415\"><\/span>\n<\/p>\n<p id=\"mmgallerylink\">\n  <span id=\"mmgallerylink-phrase\">View source version on <a href=\"http:\/\/businesswire.com\">businesswire.com<\/a>: <\/span><br \/>\n  <span id=\"mmgallerylink-link\"><br \/>\n    <a href=\"https:\/\/www.businesswire.com\/news\/home\/20200701005757\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20200701005757\/en\/<\/a><br \/>\n  <\/span>\n<\/p>\n<p>\nMerck Media:<br \/>\n<br \/>Noreen Verbrugge<br \/>\n<br \/>+ 1 (973) 937-5450<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Noreen.Verbrugge@merck.com\">Noreen.Verbrugge@merck.com<\/a><\/p>\n<p>\nPam Eisele<br \/>\n<br \/>+1 (267) 305-3558<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Pamela.Eisele@merck.com\">Pamela.Eisele@merck.com<\/a><\/p>\n<p>\nMerck Investors:<br \/>\n<br \/>Michael DeCarbo<br \/>\n<br \/>+ 1 (908) 740-1807<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Michael.DeCarbo@merck.com\">Michael.DeCarbo@merck.com<\/a><\/p>\n<p>Source: Merck &amp; Co., Inc.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Further Solidifies Merck Animal Health\u2019s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection Complements Merck Animal Health\u2019s Broad Portfolio of Vaccines and Pharmaceuticals Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck &amp; Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its previously announced acquisition of the U.S. rights to SENTINEL\u00ae FLAVOR TABS\u00ae and SENTINEL\u00ae SPECTRUM\u00ae Chews in the Companion Animal category from Virbac (NYSE Euronext:VIRP). Comprehensive parasite protection is an essential part of canine overall health and well-being. \u201cOur veterinary medicines, including parasiticides, and vaccines continue to transform the animal health industry and further solidify our position in the U.S. Companion Animal category,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cThe extensive breadth and depth of our product portfolio enhances our<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[65,74,289],"class_list":["post-741396","news_item","type-news_item","status-publish","hentry","tag-animal-health","tag-merck-animal-health","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Further Solidifies Merck Animal Health\u2019s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection Complements Merck Animal Health\u2019s Broad Portfolio of Vaccines and Pharmaceuticals Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck &amp; Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its previously announced acquisition of the U.S. rights to SENTINEL\u00ae FLAVOR TABS\u00ae and SENTINEL\u00ae SPECTRUM\u00ae Chews in the Companion Animal category from Virbac (NYSE Euronext:VIRP). Comprehensive parasite protection is an essential part of canine overall health and well-being. \u201cOur veterinary medicines, including parasiticides, and vaccines continue to transform the animal health industry and further solidify our position in the U.S. Companion Animal category,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cThe extensive breadth and depth of our product portfolio enhances our\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-08T04:37:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/\",\"name\":\"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-07-02T02:00:00+00:00\",\"dateModified\":\"2025-03-08T04:37:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/","og_locale":"en_US","og_type":"article","og_title":"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com","og_description":"Further Solidifies Merck Animal Health\u2019s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection Complements Merck Animal Health\u2019s Broad Portfolio of Vaccines and Pharmaceuticals Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck &amp; Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its previously announced acquisition of the U.S. rights to SENTINEL\u00ae FLAVOR TABS\u00ae and SENTINEL\u00ae SPECTRUM\u00ae Chews in the Companion Animal category from Virbac (NYSE Euronext:VIRP). Comprehensive parasite protection is an essential part of canine overall health and well-being. \u201cOur veterinary medicines, including parasiticides, and vaccines continue to transform the animal health industry and further solidify our position in the U.S. Companion Animal category,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cThe extensive breadth and depth of our product portfolio enhances our","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/","og_site_name":"Merck.com","article_modified_time":"2025-03-08T04:37:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/","name":"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","datePublished":"2020-07-02T02:00:00+00:00","dateModified":"2025-03-08T04:37:09+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20200701005757r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-u-s-rights-to-sentinel-brand-of-combination-parasiticides-for-companion-animals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL\u00ae Brand of Combination Parasiticides for Companion Animals"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"a89a88af-681c-4b67-bca0-0e433c5a435b","news_item_aria_label":"","media_files":[{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_multimedia\/merck_ah_2cs_tg.jpg","size":"165611","File Upload":""}],"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Animal-Health-Completes-Acquisition-of-US-Rights-to-SENTINEL-Brand-of-Combination-Parasiticides-for-Companion-Animals-2020.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/741396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":0,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/741396\/revisions"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=741396"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=741396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}